Steven G. Hughes
Chief Tech/Sci/R&D Officer bei AVIDITY BIOSCIENCES, INC.
Profil
Steven G.
Hughes is currently the Chief Development Officer at Arcturus Therapeutics, Inc. and the Chief Medical Officer at Avidity Biosciences, Inc. He previously held positions as Medical Director-UK & Ireland at Biogen Idec Ltd., Chief Clinical Development Officer at Ionis Pharmaceuticals, Inc., Chief Medical Officer at Organovo Holdings, Inc., and Chief Development Officer at Arcturus Therapeutics Holdings, Inc. Hughes holds a doctorate from Imperial College London and an MBA from Imperial College Business School.
Aktive Positionen von Steven G. Hughes
| Unternehmen | Position | Beginn |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 23.02.2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 02.01.2020 |
Ehemalige bekannte Positionen von Steven G. Hughes
| Unternehmen | Position | Ende |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 14.02.2022 |
| ORGANOVO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Corporate Officer/Principal | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Steven G. Hughes
| Imperial College London | Doctorate Degree |
| Imperial College Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
